Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001391609-18-000147
Filing Date
2018-05-30
Accepted
2018-05-30 14:50:23
Documents
52
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q/A-1 f10qa1_nulf033118.htm 10-Q/A 20614
  Complete submission text file 0001391609-18-000147.txt   1972837

Data Files

Seq Description Document Type Size
2 XBRL INSTANCE FILE nulf-20180331.xml EX-101.INS 369534
3 XBRL SCHEMA FILE nulf-20180331.xsd EX-101.SCH 29425
4 XBRL CALCULATION FILE nulf-20180331_cal.xml EX-101.CAL 31253
5 XBRL DEFINITION FILE nulf-20180331_def.xml EX-101.DEF 114106
6 XBRL LABEL FILE nulf-20180331_lab.xml EX-101.LAB 181263
7 XBRL PRESENTATION FILE nulf-20180331_pre.xml EX-101.PRE 171071
Mailing Address 2618 SAN MIGUEL SUITE 203 SAN CLEMENTE CA 92660
Business Address 2618 SAN MIGUEL SUITE 203 SAN CLEMENTE CA 92660 949-973-0684
NuLife Sciences, Inc. (Filer) CIK: 0001592603 (see all company filings)

EIN.: 463876675 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-Q/A | Act: 34 | File No.: 000-55805 | Film No.: 18867741
SIC: 2834 Pharmaceutical Preparations